R Storb

1.6k total citations
34 papers, 1.2k citations indexed

About

R Storb is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, R Storb has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in R Storb's work include Hematopoietic Stem Cell Transplantation (24 papers), Polyomavirus and related diseases (6 papers) and Acute Myeloid Leukemia Research (5 papers). R Storb is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Polyomavirus and related diseases (6 papers) and Acute Myeloid Leukemia Research (5 papers). R Storb collaborates with scholars based in United States, South Africa and Denmark. R Storb's co-authors include E. Donnall Thomas, CD Buckner, Patrick G. Beatty, Claudio Anasetti, Jean E. Sanders, Motomi Mori, R Clift, Jack W. Singer, Patrick Martin and Jan‐Stephan Sanders and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Pediatrics.

In The Last Decade

R Storb

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Storb United States 17 888 512 262 152 149 34 1.2k
RA Nash United States 17 948 1.1× 521 1.0× 272 1.0× 200 1.3× 151 1.0× 33 1.4k
PJ Martin United States 13 1.2k 1.4× 748 1.5× 268 1.0× 163 1.1× 154 1.0× 20 1.5k
H Kodo Japan 16 773 0.9× 600 1.2× 419 1.6× 238 1.6× 111 0.7× 50 1.4k
R. Or Israel 16 698 0.8× 410 0.8× 267 1.0× 101 0.7× 130 0.9× 48 1.0k
Shunro Kai Japan 16 778 0.9× 336 0.7× 277 1.1× 244 1.6× 133 0.9× 48 986
R.F. Schipper Netherlands 17 499 0.6× 871 1.7× 172 0.7× 68 0.4× 97 0.7× 27 1.3k
J. P. Laporte France 8 868 1.0× 329 0.6× 182 0.7× 425 2.8× 89 0.6× 15 1.1k
Daniela Longoni Italy 22 519 0.6× 782 1.5× 271 1.0× 188 1.2× 118 0.8× 43 1.5k
H. Baurmann Germany 18 757 0.9× 215 0.4× 211 0.8× 170 1.1× 294 2.0× 61 1.2k
GB Vogelsang United States 14 632 0.7× 272 0.5× 175 0.7× 105 0.7× 111 0.7× 22 830

Countries citing papers authored by R Storb

Since Specialization
Citations

This map shows the geographic impact of R Storb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Storb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Storb more than expected).

Fields of papers citing papers by R Storb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Storb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Storb. The network helps show where R Storb may publish in the future.

Co-authorship network of co-authors of R Storb

This figure shows the co-authorship network connecting the top 25 collaborators of R Storb. A scholar is included among the top collaborators of R Storb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Storb. R Storb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mielcarek, Marco, T Furlong, Barry E. Storer, et al.. (2015). Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial. Haematologica. 100(6). 842–848. 60 indexed citations
3.
Kornblit, Brian, DG Maloney, Barry E. Storer, et al.. (2014). A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. Haematologica. 99(10). 1624–1631. 28 indexed citations
4.
Thakar, Monica S., Peter Kurre, R Storb, et al.. (2010). Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation. Bone Marrow Transplantation. 46(4). 539–544. 16 indexed citations
5.
Wagner, John L., et al.. (1996). Molecular analysis and polymorphism of the DLA‐DQA gene.. Tissue Antigens. 48(3). 199–204. 67 indexed citations
6.
Sullivan, KM, Fritz Offner, Manfred Herold, et al.. (1994). RELATIONSHIP OF SERUM CYTOKINES (TNF-ALPHA, IL-1-BETA, IFN-GAMMA AND INFLAMMATION MARKERS (NEOPTERIN, BETA-2-MICROGLOBULIN, C-REACTIVE PROTEIN) TO TRANSPLANT-RELATED COMPLICATIONS AND IMMUNOGLOBULIN PROPHYLAXIS FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
7.
Anasetti, C, R Storb, Patrick G. Beatty, et al.. (1992). TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH A NONMITOGENIC ANTI-CD3 MONOCLONAL ANTIBODY. Transplantation. 54(5). 844–850. 50 indexed citations
8.
Stockschlaeder, Marcus, R Storb, Margaret S. Pepe, et al.. (1992). A pilot study of low‐dose cyclosporin for graft‐versus‐host prophylaxis in marrow transplantation. British Journal of Haematology. 80(1). 49–54. 27 indexed citations
9.
Storb, R. (1991). Pathogenesis and recent therapeutic approaches to graft-versus-host disease. The Journal of Pediatrics. 118(3). S10–S13. 2 indexed citations
10.
Stockschlaeder, Marcus, R Storb, William Osborne, & A. Dusty Miller. (1991). l -Histidinol Provides Effective Selection of Retrovirus-Vector-Transduced Keratinocytes Without Impairing Their Proliferative Potential. Human Gene Therapy. 2(1). 33–39. 42 indexed citations
11.
Nash, RA, F Schuening, Frederick R. Appelbaum, et al.. (1991). Molecular cloning and in vivo evaluation of canine granulocyte- macrophage colony-stimulating factor. Blood. 78(4). 930–937. 20 indexed citations
12.
Nash, RA, Friedrich Schuening, F R Appelbaum, et al.. (1991). Molecular cloning and in vivo evaluation of canine granulocyte- macrophage colony-stimulating factor. Blood. 78(4). 930–937. 6 indexed citations
13.
Anasetti, Claudio, Patrick G. Beatty, R Storb, et al.. (1990). Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Human Immunology. 29(2). 79–91. 266 indexed citations
14.
Sullivan, Keith M., Joel D. Meyers, Finn Bo Petersen, et al.. (1990). Supportive Care of the Marrow Transplant Recipient: The Seattle Experience. Hämatologie und Bluttransfusion. 33. 539–545. 5 indexed citations
15.
Appelbaum, FR, et al.. (1989). Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation. Blood. 73(8). 2202–2208. 24 indexed citations
16.
Schuening, Friedrich, R Storb, Richard A. Nash, et al.. (1988). Retroviral Transfer of Genes into Canine Hematopoietic Progenitor Cells. Advances in experimental medicine and biology. 241. 9–18. 5 indexed citations
17.
Storb, R, et al.. (1982). Alveolar macrophage kinetics and function after interruption of canine marrow function.. PubMed. 125(3). 347–51. 28 indexed citations
18.
Buckner, CD, et al.. (1979). Allogeneic marrow grafting for acute leukemia: a follow-up of long-term survivors.. Experimental Hematology. 7(10). 509–518. 21 indexed citations
19.
Weiden, Paul L., R Storb, Mang-So Tsoi, H. Joachim Deeg, & T. C. Graham. (1978). Canine osteosarcoma: Results of amputation with and without adjuvant immunotherapy. Cancer Immunology Immunotherapy. 5(3). 8 indexed citations
20.
Ed, Thomas, CD Buckner, Clift Ra, et al.. (1973). Marrow grafting in patients with acute leukemia.. PubMed. 5(1). 917–22. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by RA Nash Breakdown of academic impact, for papers by PJ Martin Breakdown of academic impact, for papers by H Kodo Breakdown of academic impact, for papers by R. Or Breakdown of academic impact, for papers by Shunro Kai Breakdown of academic impact, for papers by R.F. Schipper Breakdown of academic impact, for papers by J. P. Laporte Breakdown of academic impact, for papers by Daniela Longoni Breakdown of academic impact, for papers by H. Baurmann Breakdown of academic impact, for papers by GB Vogelsang
Rankless by CCL
2026